N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
Brad R. Henke, Steven G. Blanchard, Marcus F. Brackeen, Kathleen K. Brown, Jeff E. Cobb, Jon L. Collins, W. Wallace Harrington, Mir A. Hashim, Emily A. Hull-Ryde, Istvan Kaldor, Steven A. Kliewer, Debra H. Lake, Lisa M. Leesnitzer, Jürgen M. Lehmann, James M. Lenhard, Lisa A. Orband-Miller, John F. Miller, Robert A. Mook, Stewart A. Noble, William OliverDerek J. Parks, Kelli D. Plunket, Jerzy R. Szewczyk, Timothy M. Willson
Dive into the research topics of 'N-(2-benzoylphenyl)-L-tyrosine PPARγ agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents'. Together they form a unique fingerprint.